Skip to main content
    I

    Intelligent Bio Solutions Inc. (INBS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.56
    +0.06 (+4.00%)

    Market Cap: $4.98M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Intelligent Bio Solutions Inc. (INBS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Intelligent Bio Solutions (INBS) has a market cap of $4.98M. Its share count is up 262.15% from a year earlier. It kept -270.11% of revenue as net income over the last 12 months.

    Total Valuation

    Market Cap$4.98M
    Latest price (Nov 17, 2026)$1.56

    Key Dates

    Last Earnings DateNov 10, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count shrank 9.88% a year over 2 years.

    Shares Outstanding3.10M
    Shares Change (YoY)+262.15%
    Share Count Growth (2Y CAGR)-9.88%

    Valuation Ratios

    Sales and book value multiples are 1.1x and 0.6x.

    P/S Ratio1.1x
    Forward P/S0.8x
    P/B Ratio0.6x
    P/TBV Ratio1.0x

    Price Statistics

    The stock is down 78.34% over 52 weeks and trades 11.36% below its 50-day average.

    Beta (1Y)0.89
    52-Week Change-78.34%
    1-Month Change+1.96%
    3-Month Change-41.57%
    6-Month Change-52.58%
    5-Year Change-99.96%
    Total Return (1Y)-78.34%
    Total Return (3Y CAGR)-69.38%
    Total Return (5Y CAGR)-79.25%
    Return vs SPY (1Y)-88.95%
    Max Drawdown (1Y)-91.96%
    Max Drawdown (3Y)-97.87%
    Sharpe Ratio (1Y)-1.04
    Correlation with SPY (1Y)0.08
    50-Day Average$1.76
    200-Day Average$2.66
    52-Week Range$1.35 to $24.90
    RSI (14 Days)42.0
    Average Volume (20 Days)41.23K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.98x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.98x
    Quick Ratio1.87x
    Debt / Equity0.00x
    Interest Coverage-1482.43x

    Returns and Efficiency

    Return on equity is -160.13% and return on assets is -89.14% over the last 12 months.

    Return on Equity (ROE)-160.13%
    Return on Assets (ROA)-89.14%
    ROA (5Y Average)-95.48%
    Asset Turnover0.38x
    Inventory Turnover4.92x
    Receivables Turnover4.86x
    Cash Conversion Cycle-496 days

    Scores

    INBS has an Altman Z-Score of -9.76, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-9.76
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $4.50M over the last 12 months is up 36.55% from the 12 months before.

    Revenue$4.50M
    Revenue Growth (YoY)+36.55%
    Gross Profit$2.29M
    Operating Income-$12.29M
    Pretax Income-$12.14M
    Net Income-$12.14M
    EBITDA-$10.81M
    Reported EPS (TTM)-$6.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 55.65% of the $13.62M in total assets.

    Cash and Equivalents$5.93M
    Total Debt$0
    Net Cash$5.93M
    Net Cash Per Share$1.92
    Working Capital$4.47M
    Shareholder Equity$7.58M
    Book Value Per Share$2.45
    Tangible Book Value$4.99M
    Tangible Book Per Share$1.61
    Total Assets$13.62M
    Total Liabilities$6.27M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$11.83M
    FCF Per Share-$3.59
    Depreciation and Amortization$1.44M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -273.43%.

    Gross Margin50.94%
    Operating Margin-273.43%
    Pretax Margin-270.11%
    Net Margin-270.11%
    EBITDA Margin-240.56%

    Growth

    Revenue grew 49.68% a year over 3 years.

    Revenue Growth (3Y CAGR)+49.68%
    Revenue Growth (5Y CAGR)+16.31%

    Revenue and profit by year

    Dividends and Yields

    INBS does not pay a dividend. Its free cash flow yield is -246.75%.

    FCF Yield-246.75%
    Buyback Yield-242.11%
    Shareholder Yield-242.11%

    Stock Splits

    The last split was a 1-for-10 reverse split on Dec 16, 2025.

    Last Split DateDec 16, 2025
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 7 similar companies, INBS has the 4th highest P/S.

    P/S Ratio1.1x vs 0.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+36.55% vs +50.82% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 44.49% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+44.49%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About INBS

    What is INBS's market cap?

    Intelligent Bio Solutions has a market cap of $4.98M.

    How many shares of INBS are outstanding?

    Intelligent Bio Solutions has 3.10M shares outstanding. The count is up 262.15% from a year earlier.

    Does INBS pay a dividend?

    No. Intelligent Bio Solutions does not pay a dividend.

    How much debt does INBS have?

    Intelligent Bio Solutions has $0 of total debt and $5.93M of cash and equivalents, a net cash position of $5.93M.